The current standard for a celiac disease diagnosis is a positive blood test for specific antibodies, followed by a biopsy of the intestine that reveals damage to the villi (villous atrophy). These tests are certainly invasive and unpleasant, but more than that, they are useless in cases where a patient is already following a gluten-free diet. These patients must then undergo a “gluten challenge” of up to eight weeks, during which time they reintroduce gluten-containing foods into their diet, and suffer the consequences. Only then will the blood test and biopsy accurately reveal the hallmarks necessary for an accurate diagnosis.
1/11/2018
New Testing Option for Possible Celiac Disease Sufferers
Recent Posts
- A New Study Sheds Light On The Economic Burden Of Celiac Disease Beyond The Gluten-Free Diet
- Join Us! Celiac Disease Foundation Congressional District Days 2024 Campaign
- New Study: Ethnic Minorities with Celiac Disease Face Higher Healthcare Needs and Nutrient Deficiencies
- A Promising New Approach from Chugai Pharmaceuticals for Blocking Gluten-Induced Immune Response in Celiac Disease
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
5/1/2024
Read moreRevolutionizing Celiac Disease Diagnosis – Marilyn’s Message May 2024